Indirect effects of cytomegalovirus infection and the utility of utility of valganciclovir

被引：0
|
作者：
Martinez-Dolz, L. [1 ]
Sanchez Lazaro, I. JIgnacio Jose [1 ]
Domenech-Tort, M. D. [1 ]
Ten-Morro, F. [1 ]
Rosello-Lleti, E. [1 ]
Tarazon-Melguizo, E. [1 ]
Portoles-Sanz, M. [1 ]
Rivera-Otero, J. M. [1 ]
Salvador-Sanz, A. [1 ]
Almenar-Bonet, L. [1 ]
机构：
[1] Hosp Univ La Fe, Valencia, Spain
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：157 / 157
页数：1
相关论文
共 50 条
  • [1] Are There Indirect Effects of Cytomegalovirus Infection? Utility of Valganciclovir. EPICA Study
    Sanchez-Lazaro, I.
    Almenar-Bonet, L.
    Martinez-Dolz, L.
    Sanchez-Lacuesta, E.
    Andres-Lalaguna, L.
    Melero-Ferrer, J.
    Portoles-Sanz, M.
    Rivera-Otero, M.
    Salvador-Sanz, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S105 - S105
  • [2] Utility of Oral Valganciclovir for Cytomegalovirus Prophylaxis: Does It Improve Treatment Compliance?
    Moro, J. A.
    Almenar, L.
    Martinez-Dolz, L.
    Blanes, M.
    Aguero, J.
    Sanchez-Lakaro, I.
    Salvador, A.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (09) : 3063 - 3064
  • [3] Utility of oral valganciclovir for the treatment of cytomegalovirus disease after renal transplantation
    Pegues, David A.
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2008, 4 (01): : 18 - 19
  • [4] Utility of oral valganciclovir for the treatment of cytomegalovirus disease after renal transplantation
    David A Pegues
    Nature Clinical Practice Nephrology, 2008, 4 : 18 - 19
  • [5] The 'Indirect' Effects of Cytomegalovirus Infection
    Freeman, R. B., Jr.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (11) : 2453 - 2458
  • [6] Valganciclovir for treatment of congenital cytomegalovirus infection
    Schulzke, Sven
    Buehrer, Christoph
    EUROPEAN JOURNAL OF PEDIATRICS, 2006, 165 (08) : 575 - 576
  • [7] Valganciclovir for treatment of congenital cytomegalovirus infection
    Sven Schulzke
    Christoph Bührer
    European Journal of Pediatrics, 2006, 165 : 575 - 576
  • [8] REVEALED FAVORABILITY, INDIRECT UTILITY, AND DIRECT UTILITY
    SAKAI, Y
    JOURNAL OF ECONOMIC THEORY, 1977, 14 (01) : 113 - 129
  • [9] Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients
    Doesch, Andreas O.
    Repp, Janika
    Hofmann, Nina
    Erbel, Christian
    Frankenstein, Lutz
    Gleissner, Christian A.
    Schmidt, Constanze
    Ruhparwar, Arjang
    Zugck, Christian
    Schnitzler, Paul
    Ehlermann, Philipp
    Dengler, Thomas J.
    Katus, Hugo A.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2012, 6 : 289 - 295
  • [10] Preemptive valganciclovir for cytomegalovirus infection in hematological patients
    Focosi, D.
    Benedetti, E.
    Maggi, F.
    Papineschi, F.
    Galimberti, S.
    Ceccherini-Nelli, L.
    Petrini, M.
    TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (05) : 375 - 376
12345